Calando
Arrowhead Research this week reported its fiscal fourth-quarter financial results, posting a higher net loss amid increased operating expenses.
The company also said that efforts to integrate its subsidiaries into a single company are underway.
People in the News: Jul 28, 2011
Premium
Timothy Triche
The CEO of Calando parent firm Arrowhead Research also said that the RNAi shop has restarted preclinical research and development — a notable departure from events in 2009 when the company stopped all such work and shuttered Calando's lab amid a cash crunch.
Apr 28, 2011
People in the News: Apr 28, 2011
Premium
Jan 27, 2011
Jan 20, 2011
Dec 9, 2010
Sep 30, 2010
Sep 23, 2010
Aug 19, 2010
Apr 29, 2010
People in the News: Apr 29, 2010
Premium
Mar 25, 2010
Mar 11, 2010
Feb 18, 2010
Nov 12, 2009
Nov 5, 2009
Nov 5, 2009